Stock screenerAll disclosures →
EDGAR →
KROS
Conviction 8HealthcareScan · Thu, Jun 25, 2026KROS$10.40-4.76%
ResistanceSupportVol 14Insider buyInsider sell3
Vol MA14 252.73K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price10.40
Change-4.76%
Gap-0.18%
Rel volume1.42×
Avg volume238.15K
Avg $ vol2.51M
SMA 2010.52
SMA 5011.03
SMA 20014.88
Price vs 50-5.67%
Price vs 200-30.09%
MA stackbearish
50/200 cross—
Supertrenddown · 11.51
RSI (14)45
MACD hist0.09
MACD crossbull · 5d
Stoch %K / %D40 / 61
ADX (14)15
+DI / −DI22 / 21
RSI divergence—
MACD divergence—
ATR %+5.12%
ADR %4.53%
52w high21.84
52w low9.91
From 52w high-52.38%
Above 52w low+4.94%
New 52w highNo
SqueezeOff
Bollinger width16.32%
%B0.43
Donchian pos37.57%
Donchian high11.58
Donchian low9.69
AVWAP (52w high)14.59
vs AVWAP high-28.74%
AVWAP (52w low)10.55
vs AVWAP low-1.41%
OBV trendFlat
Chaikin MF (20)-0.28
Today vs 20d1.42×
Avg vol (14d)252.73K
Avg vol (20d)238.15K
Avg $ vol (20d)2.51M
Market cap205.84M
RS 3m (vs SPY)-12.89%
RS 6m (vs SPY)-53.84%
RS line new highNo
Trend template0/8
Technical rank14.2
1 week-0.10%
1 month-7.39%
3 months-8.29%
6 months-51.27%
1 year-24.14%
YTD-43.91%
P/E2.37
P/B0.72
P/S0.84
P/FCF1.94
EPS2.30
Div yield—
ROE30.46%
ROA27.86%
Debt/Eq—
Current22.62
EV/EBITDA—
Gross margin—
Net margin35.65%
Rev growth—
EPS growth146.44%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-75.66M
Revenue367K
Net income-23.71M
Gross profit—
Free cash flow105.95M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out19.79M
Employees87
ListedWed, Apr 8, 2020
Free float18.42M
Float %93.1%
Short interest1.51M
Days to cover4.5d
Short volume34.2%
Squeeze score45 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$1.25 · 4 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank14.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance12.14
Support9.74
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KROS
No recent disclosed trades by Congress in KROS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KROS · 5 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BIENAIME JEAN JACQUES Director · Common Stock · 2026-06-15 | Buy | 1K | $10K | 2026-06-15 | 2026-06-17 |
Knowles Julius Director · Common Stock · 2026-06-04 | Sell | 2.63K | $28K | 2026-06-04 | 2026-06-08 |
Farzan Nima Director · Common Stock · 2026-06-04 | Sell | 2.63K | $28K | 2026-06-04 | 2026-06-08 |
Knowles Julius Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
Seth Alpna Director · Common Stock · 2026-06-04 | Sell | 2.63K | $28K | 2026-06-04 | 2026-06-05 |
Knowles Julius Director · Common Stock · 2026-06-03 | Other | — | — | 2026-06-03 | 2026-06-05 |
Farzan Nima Director · Stock Option (right to buy) · 2026-06-03 | Grant | 7.43K | $0 | 2026-06-03 | 2026-06-05 |
Farzan Nima Director · Common Stock · 2026-06-03 | Grant | 7.14K | $0 | 2026-06-03 | 2026-06-05 |
Seth Alpna Director · Common Stock · 2026-06-03 | Grant | 7.14K | $0 | 2026-06-03 | 2026-06-05 |
GRAY MARY ANN Director · Stock Option (right to buy) · 2026-06-03 | Grant | 7.43K | $0 | 2026-06-03 | 2026-06-05 |
SEC filings
EDGAR filings in KROS · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.